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 Abstract: Alpha-synuclein has been implicated in the cellular mechanisms 
that control auditory sensitivity.  In other systems it can also confer 
protection against cellular injury.  Auditory brainstem response thresholds 
and immunohistochemistry were used to assess the ability of alpha-synuclein 
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INTRODUCTION AND REVIEW OF THE LITERATURE 
 
 
Auditory Physiology and Cochlear Mechanics 
 The cochlea is a structurally and functionally complex organ. Sound is funneled through 
outer ear and transmitted through the middle ear to the cochlear fluids where the final effect is to 
stimulate, appropriately, the sensory hair cells of the cochlea. The mammalian cochlea contains 
two classes of hair cells arranged in rows along the organ of Corti. Hair cells are neuroepithelial 
cells (Ashmore, 2008). Only a portion of the physiologic mechanisms used to enhance the 
auditory systems sensitivity have been correctly identified. The presence of two different classes 
of hair cells, the inner hair cell (IHC) and outer hair cell (OHC), in the organ of Corti were 
appreciated nearly one hundred years ago, yet the function of these cells have only become 
apparent in recent years. There are approximately 3,500 IHC and 11,000 OHC in each human 
cochlea (Ashmore, 2008). Anatomical studies indicate that the majority of the nerve fibers 
carrying information to the brain are in contact with IHC. This infers that most of the 
information from our acoustic world reaches the brain by means of the IHC (Alfred, 2006). We 
are aware that the cochlear amplifier is a functional process which has been determined to 
enhance the frequency selectivity of the cochlea due to a source of mechanical energy which is 
controlled by OHC motility. This amplifier contributes to physiologic auditory enhancement due 
to the OHC actively responding to acoustic stimulation. Hearing is known to be degraded when 
the OHC are damaged, likely due to the fact that the cochlear amplifier refines the sensitivity 
selectivity of the mechanical vibrations of the cochlea (Alfred, 2006) yet less is known about the 
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signal transduction between hair cells and the cochleovestibular nerve that carries the auditory 
signal from the cochlea to the brain. 
 
Synuclein Proteins  
Synuclein proteins are small, soluble proteins expressed primarily in neural tissues 
(Surguchov, 2008). The first synuclein was identified and named by Maroteaux, et al. (1988). 
Maroteaux and colleagues discovered synuclein proteins in neural nuclear envelopes as well as 
pre-synaptic terminals (Maroteaux, et al., 1988 and Surguchov, 2008). The synuclein family of 
lipid binding proteins includes three known proteins: α-synuclein, β-synuclein, and γ-synuclein. 
Alpha and beta synuclein proteins are primarily localized to the brain, while γ-synuclein is 
localized more broadly, in tissues including brain, peripheral nerve, retina, and several tumors. 
Gamma-synuclein is a known marker for breast cancer (Ji et al., 1997).  
Alpha-synuclein has an easily changeable conformation. This configuration is altered 
considerably upon lipid binding and interactions with other ligands (Surguchov, 2008; Perrin, 
2000). Alpha-synuclein also has many molecular isoforms that are generated as a result of 
different posttranslational modifications, alternative splicing, truncation, aggregation states and 
binding to other proteins and ligands. These isoforms have different features including 
conformation and localization (Surguchov, 2008).  Due to these features, synucleins tend to 
transition from one form to another with changing properties. These properties depend on the 
physiological conditions of the cells and tissues where synucleins are expressed and make it 
increasingly difficult to define the protein’s function. 
The majority of papers devoted to the synucleins admittedly indicate that the normal 
physiologic function of α-synuclein remains unknown (Surguchov, 2008). However, copious 
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research articles have suggested possible functions of the protein and list multiple processes 
which synucleins are involved in. These possible functions include synaptic plasticity, 
maintenance of the synaptic vesicle pool, and chaperone activity (Surguchov, 2008). Therefore, 
while the functional role of α-synuclein may not be clearly defined, it is related with the 
maintenance of synaptic vesicle pools and also plays a role in several other cellular processes.   
As previously stated, synuclein proteins are necessary for synaptic regulation and vesicle 
transport. Due to their function in synaptic regulation and vesicle transport, synuclein proteins 
are therefore likely involved in the synaptic activity of the auditory system. It was recently found 
that mice with targeted deletions of the gene that codes for alpha-synuclein exhibit elevated 
auditory brainstem response thresholds, suggesting a role for this protein in normal hearing 
mechanisms.  
Over the past two decades, synuclein research has been highlighted with intriguing 
hypotheses, stimulating conclusions, and controversial information. Polymeropoulos, et al. 
(1997) were amongst the first to indicate that α-synuclein is genetically and neuropathologically 
linked to Parkinson’s disease.  
 
Localization of Synucleins in the Cochlea 
As previously mentioned, synucleins have been localized to the presynaptic nerve 
terminals and nucleus. There is also research supporting the axonal transport of synuclein to the 
nerve terminals and the association of synuclein with synaptic vesicles (Surguchov, 2008). 
Alpha-synuclein has commonly been localized to the efferent cholinergic neural auditory 
system. This is suggestive that alpha-synuclein plays a role in normal auditory function and in 
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turn, insinuates that this synuclein plays a role in auditory neurodegenerative disorders (Akil, et 
al., 2008). 
In 2008, Akil, et al. localized the three synuclein isoforms, alpha, beta, and gamma, 
within the mouse cochlea. Alpha-synuclein was localized predominantly to the base of IHC and 
OHC as well as the efferent tunnel crossing fibers. Knowing that alpha-synuclein localizes 
prominently to the neuronal system within the cochlea, it is essential to study the hair cell 
synapse. 
 
Role of Paraquat in Free Radical Damage 
Oxidative stress and free radicals are known to induce metabolic damage to structures, 
including the auditory system. Paraquat herbicide has been known to cause oxidative stress and 
the generation of free radicals. Paraquat has also been linked to neurodegenerative disorders, 
possibly due to the interaction between paraquat and the dopamine system (Thiruchelvam, et al., 
2000). Paraquat has been identified as a known inducer of apoptosis in neural cells (Melchiorri, 
et al., 1998) 
Paraquat is a toxic herbicide used primarily in third world countries that produces high 
levels of superoxide (Nicotera, et al., 2004 and Bielefeld, 2005). Superoxide is the product of the 
one-electron reduction of dioxygen, and has been identified as a contributing factor to cochlear 
pathology from sources including noise and ototoxic drugs. Ototoxicity appears to be mediated 
primarily by the superoxide radical. The exact function of the superoxide radical in regards to 
cochlear damage is unclear (Nicotera, et al., 2004) but the excess production of superoxide 
radical is sufficient to cause cochlear damage and hair cell loss. 
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Paraquat has been identified as causing oxidative stress (Nicotera, et al., 2004). Oxidative 
stress has been proposed as a common factor in the etiology of sensorineural hearing loss 
(SNHL). By increasing the concentration of paraquat to a system, which can easily navigate 
through cell membranes, there is a systematic decrease in the number of hair cells. Nicotera, et 
al. identified that exposing in vitro samples of cochlear cultures to paraquat for 24 hours resulted 
in the destruction of OHC and IHC in a dose dependent fashion where the number of hair cells 
decreased in parallel with increasing concentration of paraquat. Contrary to most ototoxic drugs, 
there was no evidence that paraquat destroyed OHC before IHC. This is a similar pathological 
result to a SNHL. 
Bielefeld, et al. (2005) performed inferior colliculus evoked potential testing on paraquat 
affected systems. Their results indicated similar findings in that inferior colliculus evoked 
potentials increase in threshold in a dose dependent manner. The paraquat treatment lead to a 
change in hearing threshold across the tested frequency range of 500Hz, 10kHz, 20kHz, 40kHz, 
and 80kHz. These results imply that paraquat affected cells from base to apex. A dose response 
to 10mM induced the greatest permanent threshold shift with mean shifts of 30-45dB. Ten 
millimolars of paraquat induced the greatest OHC and IHC loss with more damage occurring at 
the basal end than the apical end. 
In 1996, Clerici and Yang first indicated that generators of superoxide, such as paraquat, 
induced significant shifts in the compound action potential threshold when introduced into the 
perilymph (Bielefeld, et al., 2005). The electron transport chain in the mitochondria is thought to 
be a major source of intracellular superoxide. Hair cells are known to be highly demanding of 
energy and consuming of large amounts of oxygen (Bielefeld, et al., 2005). Paraquat would 
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increase the demand for oxygen and tax the mitochondria causing more superoxide to be 
produced.  
 
Synucleins and Parkinson’s disease 
Due to the localization of alpha-synuclein and the ability of the protein to perform as a 
synaptic regulator, it has been suggested to play a role in neural regulation as well. Parkinson’s 
disease is a common neurodegenerative disorder characterized by the loss of dopaminergic 
neurons in the nigrostriatal pathway and the formation of intraneuronal inclusions called Lewy 
bodies. Alpha-synuclein is a major component found in Lewy bodies in Parksinson’s disease 
patients (Li, et al., 2005) and alpha-synuclein mutations have been associated with clinical and 
pathological Parkinsonism in rare autosomal dominant familial cases (Polymeropoulos, et al. 
1997) Therefore, alpha-synuclein aggregation may be the cause of Lewy body formation and 
neurodegeneration (Manning-Bogt, 2001). 
Upregulation of alpha-synuclein occurred when interactions between alpha-synuclein and 
paraquat in vitro studies were performed. (Manning-Bogt, 2001) Microscopic examination 
showed enhanced immunoreactivity in the midbrain of paraquat treated animals as well as a 
robust alpha-synuclein staining in the substantia nigra pars compacta after being exposed to the 
herbicide paraquat. (Manning-Bogt, 2001)  
 
Endocochlear Potential  
The endocochlear potential (EP) is an electrochemical potential found in the inner ear. 
The EP is a positive voltage of 80 - 100 mV seen in the endolymphatic space of the cochlea 
relative to surrounding spaces. It is highly dependent on metabolism and ion transport. In the 
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event of anoxia, an occluded blood supply or treatment with ion transport inhibitors such as 
ethacrynic acid or furosemide, the EP rapidly falls and becomes negative. Paraquat induced 
oxidative stress, which causes the generation of free radicals, would result in a metabolic change 
if introduced to the inner ear. The stria vascularis, which is thought to be responsible for 
maintaining the EP is susceptible to metabolic damage. Therefore, it is possible that by inducing 
metabolic changes within the inner ear, which would affect the stria vascularis, the EP may be 
subsequently altered as well.  
 
Synucleins in Vesicle Recovery at Ribbon Synapses 
Inner hair cells in the cochlea possess a unique synaptic specialization, a synaptic ribbon. 
Alpha-synuclein likely plays a regulatory role at the synaptic base of the synaptic ribbon. The 
electron-dense synaptic ribbon, or the synaptic body, of the hair cell afferent synapse has been 
recognized for decades and its known precision to code the temporal fine structure of acoustic 
stimuli is unparalleled. (George, n.d.) 
Cochlear afferent neurons are faced with the challenge of encoding sounds of different 
intensities and durations. For this, they must rely on synaptic mechanisms that allow a high 
degree of temporal fidelity, yet can sustain a high level of neurotransmitter release. The hair cell 
afferent synapse’s capacity for sustained signal has been attributed to the presence of the 
synaptic vesicles (Nouvian, et al., 2006). 
Both directly-attached vesicles, referred to as docked vesicles, and nearby undocked 
vesicles constitute a pool of synaptic vesicles that could sustain seconds of exocytosis at most. 
With stimulation exhausting the number of docked vesicles, it is assumed that ongoing 
spontaneous and sustained driven release of hair cells requires mechanisms for rapid and 
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efficient replenishment of the readily releasable pool of vesicles (Fuchs, et al., 2003). Both 
physiological and anatomical evidence implicate alpha-synuclein in the regulation of synaptic 
vesicle populations within the presynaptic terminal.  
Murphy, et al. (2000) examined the presynaptic morphology of cultured hippocampal 
neurons in which alpha-synuclein expression was partially reduced by treatment with antisense 
oligonucleotides.  The numbers of docked vesicles were unchanged by antisense treatment. 
However, there was a significant decrease in the distal or undocked pool of synaptic vesicles in 
the alpha-synuclein depleted cells versus controls.  
Studies using gene knock-out (KO) technology in mice also support a role for alpha-
synuclein regulation of synaptic vesicle populations. Alpha-synuclein KO mice (Cabin, et al., 
2002) displayed 50% fewer undocked vesicles in hippocampal synapses than wild type animals, 
while the numbers of docked vesicles remained unchanged. These mice had normal 
electrophysiological responses to stimuli expected to deplete only docked vesicles, but showed 
impaired responses to prolonged repetitive stimuli, which deplete both docked and undocked 
vesicles. Alpha-synuclein KO mice show impaired synaptic responses to stimulation designed to 
deplete docked vesicles as well as reserve pool vesicles (George, n.d.). This was interpreted to 
mean that replenishment of vesicles by the reserve population was slower. Therefore alpha-
synuclein may be required for the maintenance of a ‘reserve’ subset of presynpatic vesicles.  
As previously stated, the presence of alpha-synuclein likely aids in the maintenance of 
synaptic vesicles, researchers have investigated the over-expression of alpha-synuclein in 
synaptic regulation. Alpha-synuclein mice were not found to differ from wild-type animals in 
numbers of dopaminergic neurons in the substantia nigra (Abeliovich, et al., 2000). This is a 
surprising result, given the known association of human alpha-synuclein mutations with 
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nigrostriatal degeneration. The transgenic mice did exhibit more rapid recovery of dopamine 
released in a paired-stimulus paradigm. The authors conclude that alpha-synuclein negatively 
regulates dopamine neurotransmission, perhaps by recycling of the readily releasable (docked) 
pool of presynaptic vesicles. 
In summary, evidence indicates that alpha-synuclein has a fundamental role in the 
maintenance and availability of synaptic vesicle pools in the presynaptic terminal. One might 
therefore reasonably expect that transgenic mice that over-produce alpha-synuclein would have a 
greater number of docked vesicles, and might more readily replenish the readily releasable pool 
of vesicles. This would ensure continued signal transmission during prolonged sounds. 
 
Alpha Synuclein and Neuroprotection 
While it has been suggested that alpha-synuclein is likely to play a role in 
neurodegenerative processes that underlie Parkinson’s disease (Polymeropoulos, et al., 1997), 
some studies indicate a neuroprotective role of alpha-synuclein. In support of this hypothesis, in 
vitro findings have indicated that incubations of recombinant alpha synuclein in the presence of 
paraquat resulted in a dramatic acceleration of protein fibrillation. Mice that were exposed to 
either paraquat or Parkinson-inducing toxicant MPTP exhibited an up-regulation of alpha-
synuclein that appeared to be a part of a neuronal response to toxic insults (Manning-Bogt, 
2001). Moreover, while mice over-expressing alpha-synuclein displayed paraquat-induced 
protein aggregates, they were completely protected against neurodegeneration (Manning-Bogt, et 
al., 2003). Using mice with transgenic expression of human wild-type versus Ala53Thr mutant 
alpha-synuclein, there was no indication of a significant difference between paraquat 
neurotoxicity in either mouse with alpha-synuclein over-expression. Collectively, these findings 
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dissociate toxicant-induced alpha-synuclein deposition and neurodegeneration, and argue that 
alpha-synuclein plays a protective role against toxic insults. 
 
Present Study 
The present study sought to evaluate the effect of alpha-synuclein on paraquat toxicity. 
We designed a protocol to evaluate whether paraquat induced oxidative stress is capable of 
causing a significant loss of auditory function. We also tested whether over-expression of alpha-
synuclein is protective against oxidative damage in the cochlea. Protection was measured by 



















MATERIALS AND METHODS 
 
Animals and paraquat administration 
Genetically altered mice provide useful models for auditory neuroscience research and 
serve as highly effective models for assessing the function of the synuclein proteins in the 
auditory system. (Willot, et al., 1996) Two separate groups of mice were considered to evaluate 
the effects of paraquat and alpha-synuclein. A control group was comprised of six wild-type (wt) 
CBA/CaJ littermate animals. Three control animals received paraquat injections while three 
control animals received no treatment. A second group of twelve M83 transgenic C57-BL/6 
mice; a sixth generation backcrossed onto a CBA/CaJ strain, and their wt littermates were 
studied to evaluate the effects of alpha-synuclein on oxidative damage in the cochlea. The M83 
transgenic mice were bred with a gene for human alpha-synuclein inserted in order to produce 
excess amounts of this protein. All twelve animals, nine M83 transgenic animals and three wt 
littermates, received paraquat injections. Mice were purchased directly from The Jackson 
Laboratory (JAX) or were derived from breeders purchased from JAX. Prior to procedures and 
between test times, the animals were housed in a quiet colony in an approved facility at 
Washington University. They were kept on a 12/12-light/dark cycle. Food and water were available 
on an ad-lib basis. 
Paraquat dichloride (Sigma) was dissolved in saline to a final concentration of 1mg/ml. 
Mice received intraperitoneal (i.p.) injections of paraquat dichloride hydrate twice a week for 
four consecutive weeks. Hearing sensitivity was assessed weekly for the duration of the 





To test hearing sensitivity, electrophysiologic evaluations were assessed by evoked ABR 
thresholds performed on M83 homozygous, heterozygous, and wild type mice. Threshold 
sensitivity was evaluated by ABR prior to paraquat treatment in order to obtain baseline hearing 
sensitivity thresholds. Animals were tested weekly following i.p. injections of paraquat 
(10mg/kg). Testing was performed at four time points; one week post 2 injections, two weeks 
post 4 injections, 3 weeks post 6 injection, and four weeks post 8 injections. Pre-exposure 
thresholds were subtracted from the four week measurements to calculate threshold change at 
each frequency time point.  
Tucker-Davis Technologies (TDT) System II hardware and BioSig 32 software were 
used. Calibration occurred prior to each recording session. Animals were intraperitoneally 
injected with a solution of ketamine and xylazine (80/15 mg/kg) to achieve a deep plane of 
anesthesia. Subdermal needle electrodes were placed in the mid-back (ground), medial to the 
pinna of the tested ear (active), and at the vertex (reference). Animal’s body temperature and 
heart rate were monitored throughout testing by using a rectal probe. Body temperatures were 
maintained at 37.5 ± 1.0°C using an isothermal pad. The right ear of each mouse was stimulated 
with 5 msec tonebursts (1000 repetitions, 20/second, 1.0 msec rise time) at frequencies of 5, 10, 
20, 28.3, and 40 kHz. Filter settings were 100 to 10,000 Hz and speaker distance was 7 cm. ABR 
waveforms were recorded in 5dB (SPL) intervals and thresholds were identified by visual 
inspection. The first wave of the ABR is thought to be generated by early auditory nerve and 
cochlear activity and is the most robust wave of the mouse ABR (Zheng et al., 1999)  Thresholds 
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were observed as the lowest level that the first peak (wave I) was visualized. All mice used for 
evaluation had baseline thresholds within normal limits.  
 
Histological Assessment  
 
Tissue Preparation 
Localizing the synuclein protein provided helpful cues in speculating the functional role 
the synuclein family plays in the cochlear structures. Following the final physiological 
measurements, animals were sacrificed by cervical dislocation. Cochlear structures were 
dissected and tissues were preserved using transcardial or round window perfusions to conserve 
pertinent cochlear structures. Cochlear structures were then embedded in paraffin and sectioned 
in the midmodiolar plane.  
 
Immunohistochemistry 
 Parrafin sections were washed in xylene and ethanol solutions for deparaffination 
procedures. Prior to staining, all sections were pre-incubated in normal goat blocking serum for 
30 minutes at room temperature. For oncomodulin immunohistochemistry, sections were 
incubated in oncomodulin primary solution (rabbit anti ocomodulin 1:500) for 4 hours before 
being rinsed in PBS solution 3 times for 5 minutes. Secondary antibody goat anti rabbit Alexa 
fluorescence 546 (1:200) was then applied to sections which were incubated for 30 minutes. 
Sections were washed in PBS solution 2 times for 5 minutes. 
 For alpha-synuclein immunofluorescence staining, Sections were incubated for 4 hours in 
primary guinea pig anti alpha-synuclein antibody (Abcam 16784) solution (1:2,000). After 
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washing sections in PBS solution 3 times for 5 minutes, sections were incubated with the 
corresponding secondary antibody, goat anti guinea pig (Molecular Probes 1:250) for 30 
minutes. Sections were washed in PBS solution 2 times for 5 minutes prior to cover-slipping the 
sections for observation. 
 For beta-synuclein, sections were incubated in primary rabbit anti beta-synuclein 
(Epotomics 1537Y 1:200) for 4 hours. Sections were washed in PBS solution 3 times for 5 
minutes prior to being incubated with corresponding goat anti rabbit secondary (Alexa 
fluorescence 488 1:250). Sections were rinsed in PBS solution 2 times for 5 minutes prior to 
cover-slipping for observation. 
 Gamma-synuclein immunofluorescence was performed by applying primary goat anti-
gamma-synuclein antibody (Santa Cruz 10698 1:150) for 4 hours. Sections were then washed in 
PBS solution 3 times for 5 minutes and incubated with corresponding rabbit anti goat secondary 
(Alexa fluorescence 594 1:250). Sections were washed in PBS solution 2 times for 5 minutes 
prior to cover-slipping for observation. 
 For all samples, alpha-, beta-, and gamma-synuclein, slides treated with the same 
technique but without incubation of the primary antibody were used as a control. Slides were 
observed using a Zeiss confocal microscope.  
 
Statistical Analyses 
In order to assess the possible function of α-synuclein, a comparison of mean values of ABR 
threshold changes were compared between M83 transgenic mice and wt M83 mice was 
performed with two-way analyses of variance (ANOVA) with Bonferroni correction. A Holm-
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Sidak multiple comparisons significance was defined as a p value less than 0.001. This test was 





























Baseline Auditory Thresholds 
 Figure 1 indicates baseline auditory thresholds of the M83 transgenic animals and their 
wt littermates. Electrophysiological responses for initial hearing sensitivity revealed there to be 
no obvious phenotype, either physical or behavioral, observed in the transgenic alpha-synuclein 
mouse relative to wt littermates. 
 
Threshold Changes 
Figure 2 represents the results of the mean threshold shift for the control study used to 
confirm paraquat toxicity. A mean threshold for all six wt control CBA/CaJ mice indicate 
indicates a baseline threshold of hearing sensitivity for these wt animals. Three animals received 
no treatment, and three animals received eight paraquat injections, two times a week for four 
weeks. A Two-Way Repeated Measures ANOVA revealed a significant interaction between 
treatment and frequency (p< 0.001). The effect of treatment within frequency was significant at 
all frequencies tested. 
 Figure 3 represents the overall threshold change for M83 transgenic animals and their wt 
counterparts. All twelve animals received paraquat injections twice a week for four consecutive 
weeks. Overall threshold change was then calculated by subtracting pre-exposure baseline 
thresholds from the four week threshold measurements at each frequency tested. A Two-Way 
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Repeated Measures ANOVA revealed no significant interaction between treatment and 
frequency for threshold shifts across the range of frequencies tested. The Holm-Sidak multiple 




In completing post mortem histological examinations on the mice tested in the study, it was 
found that the general cochlear architecture was sound. Immunohistological analysis of wt and 
control mice indicated the presence of alpha-synuclein in the murine cochlea. Triple labeling 
immunofluorescence was performed to determine the location of the synuclein isoforms within 
the inner ear. As seen in Figure 4, OHC are labeled in blue by a calcium binding protein, 
oncomodulin. Supporting Dieter’s cells are labeled with antibodies to gamma-synuclein as seen 
in burgundy. Alpha-synuclein, labeled in green, was consistently concentrated in the synaptic 
base of OHC and IHC between oncomodulin positive OHCs and gamma synuclein positive 
Dieter’s cells. Alpha-synuclein was also localized to the efferent tunnel-crossing fibers and beta-
synuclein was localized primarily to the spiral ganglion (data not shown).  
 
Immunofluorescence in the M83 Transgenic Mouse 
Immunofluorescence within the M83 alpha-synuclein transgenic mouse model indicated 
alpha-synuclein expression primarily in the base of OHCs, weakly at the base of IHC, and 
strongly in the stria vascularis as seen in Figure 5. Immunofluorescence within the wt mouse 
model indicated the presence of alpha-synuclein at or near the base of OHCs, weakly at the base 






Research is needed to assess the functional and histological role of the alpha-synuclein 
protein in hopes of identifying the role of this synuclein isoform in neural function and 
neurodegenerative diseases. The recent identification of the synuclein proteins within the 
auditory neuronal system raises interesting questions about their functional role and possible 
pathological or protective attributes within the inner ear.  
Initial research identified and outlined the ribbon synapse surrounded by both docked and 
undocked synaptic vesicles. These ribbon synapses are located within the mammalian inner ear, 
and are specifically associated with hair cells in the organ of Corti. Prior work by other groups 
provided evidence that alpha-synuclein, which has been identified as a synaptic regulator, has an 
effect on the number of undocked synaptic vesicles available to the ribbon synapse. The number 
of undocked synaptic vesicles decreases when the expression of alpha-synuclein was reduced. 
Therefore the undocked synaptic vesicles, which are necessary to replenish the docked vesicles 
as they are fired in response to stimulus, are less efficient at replacing the docked vesicles and 
achieving the accurate response to stimulus which is necessary to preserve hearing sensitivity. 
Mice with a decrease in alpha-synuclein expression had normal electrophysiological responses to 
stimuli expected to deplete only docked vesicles, but impaired responses to prolonged repetitive 
stimuli, which depletes both docked and undocked vesicles.  
We confirmed the presence of the three synuclein isoforms within the mammalian organ 
of Corti. Alpha-synuclein profiles were localized at or near the base of both IHC and OHC. By 
locating this synuclein protein to the synaptic terminals, we can further support the hypothesis 
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that alpha-synuclein functions as a regulator of synaptic transmissions between sensory hair cells 
and spiral ganglion neurons. 
Immunofluorescence in the M83 transgenic mouse model indicated an up-regulation in 
alpha-synuclein expression in the stria vascularis compared to wt littermates. Endocochlear 
potential testing was performed on several M83 transgenic mice to evaluate a potential effect of 
this upregulation. The EP values measured fell in the normal range for C57/B6 mice. However, 
these measures were surprisingly variable. We intend to repeat the EP measurements once our 
mouse model is fully backcrossed to a CBA background.  
Electrophysiological results indicated that by introducing paraquat herbicide to the 
auditory system, the system would be put in oxidative stress and, as a result, hearing threshold 
sensitivity increased at all frequencies tested. Knowing that paraquat induced oxidative stress 
caused a functional loss of hearing; paraquat was introduced to the murine model over-
expressing alpha-synuclein. The over expression of alpha-synuclein was hypothesized to have a 
protective effect on the neurodegenerative result of paraquat. Our ABR data in the M83 
transgenic and wt animals did not indicate a significant change in threshold; however M83 
transgenic animal’s thresholds consistently remained closer to baseline thresholds when 
compared to their wt littermates over the majority of frequencies tested 
We can infer then that paraquat does cause oxidative stress leading to a loss of auditory 
function and augmented levels of alpha-synuclein appear to play a protective role in synaptic 
preservation. It is possible that functional ABR’s may not be specific enough to identify this 
protective role. Further testing should be conducted to evaluate the potential protection against 
the loss of auditory sensitivity due to alpha-synuclein over-expression.  
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This neuroprotective effect is at odds with findings in other experimental systems that 
have indicated a relationship between alpha-synuclein and neuronal injury. However there has 
been evidence that increased levels of alpha-synuclein do not necessarily lead to neurotoxicity 
due to the fact that AS over-expression in transgenic mice does not consistently induce neuronal 
damage. (Matsuoka, et al., 2001) 
In agreement with our results, there have been in vitro findings that AS may play a 
protective role when faced with apoptotic stimuli. (Hashimoto, 2002). Our current results and 
previous data indicate that the toxic consequences of alpha-synuclein expression may vary 
significantly. The role pf alpha-synuclein must therefore be considered relative to specific 
tissues.  
 
Limitations of the present study  
One shortcoming of this experiment was the small sample size. It is likely that with a much 
larger subject population for paraquat injection and electrophysiologic assessment, a significant 
effect may be seen across the range of frequencies tested.  
The mice used in this study come from a mixed background. Currently we are crossing a 
C57-BL/6 mouse to a CBA/CaJ background. This may account for some of the variability 
between mice.   
 
Clinical Implications and Future Studies 
 
 This current study was limited to the evaluation of hearing sensitivity alone. Future 
testing using the M83 transgenic mouse model and paraquat herbicide should include additional 
functional testing in order to identify a specific mechanism or site of protection. A battery of 
testing would be more appropriate. This battery should include EP testing to further examine the 
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effects of up-regulation within the stria vascularis of the M83 transgenic mouse as well as 
distortion product otoacoustic emissions testing to evaluate the effects of the protein on the 
cochlear amplifier. Gap Detection testing should be performed to evaluate the IHC and central 
auditory pathway, and finally additional ABR testing with an increased number of M83 
transgenic animals and their wt littermates is appropriate once the mice are fully backcrossed 
onto a CBA/CaJ background. A histological evaluation including hair cell counts to evaluate 
damage would be necessary for the correlation of these functional tests. This battery of testing 
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Figure 1- Baseline Auditory Thresholds: This is a line graph representing the mean ABR 
baseline threshold for M83 transgenic and their wild-type littermates. On the x-axis is 
frequency in kHz and the y-axis represents amplitude in dB SPL. The blue triangles 
represent the M83 transgenic animal’s mean baseline hearing threshold at each frequency 
tested. The red boxes represent the wt animal’s mean baseline hearing threshold at each 
frequency tested. This graph depicts that no obvious phenotype, either physical or 
behavioral, was observed in the transgenic alpha-synuclein mouse relative to wt littermates 










Figure 2 – Overall Threshold Shift: This is a line graph indicating the threshold change of 
the control CBA/CaJ group of animals. On the x-axis are frequencies tested in kHz. The y-
axis indicates ABR threshold in dB SPL. The blue circles represent the mean baseline 
thresholds for all control animals. The red squares represent the ABR thresholds of mice 
that did not receive paraquat injections. The green triangles represent the ABR thresholds 
of animals who received the paraquat protocol of 8 injections over a 4 week time interval. 
A Two-Way repeated Measures ANOVA revealed a significant interaction between 
genotype and frequency, p < 0.001 (0.0000441). Genotype within frequency was significant 







Figure 3 – Overall Threshold Change: This is a bar graph indicating the overall threshold 
change for M83 transgenic animals and their wt counterpart mice.  On the x-axis is 
frequency in kHz and the y-axis is ABR thresholds change in dB SPL. Threshold change 
was calculated by subtracting pre-exposure thresholds from the four week threshold 
measurements at each frequency tested. The blue bar represents the M83 transgenic 
animals, and the red bar represents their wild-type counterparts. By looking at this graph, 
it seems as though the M83 homozygous mice have better thresholds, but this difference is 











Figure 4 – Synuclein localization in the Normal Mouse organ of Corti: This is an example 
of triple label immunofluorescence localizing each of the synuclein isoforms. In this photo 
the outer hair cells have been labeled with the calcium binding protein, oncomodulin, in 
blue. Dieter’s cells are labeled with antibodies to gamma-synuclein as seen in burgundy. 
Alpha-synuclein profiles, presumably synaptic terminals, are labeled green and appear to 
lie near the base of IHCs and OHCs, between oncomodulin-positive OHCs and gamma-
















Figure 5 – Immunofluorescence in the M83 Transgenic Mouse: This is an example of 
alpha-synuclein immunofluorescence localizing in an M83 transgenic animal. In this photo 
alpha-synuclein, labeled in green, is expressed primarily in the synaptic base of the outer 
hair cells as well as in the stria vascularis. Immunofluorescence within the wild type mouse 
model indicates the presence of alpha-synuclein, in green, at or near the base of outer hair 
cells and the absence of alpha-synuclein in the stria vascularis. OHC have been labeled in 
red for landmark purposes. There is an obvious up-regulation of alpha-synuclein in the 
stria vascularis of the M83 transgenic mouse model.  
 
 
